mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.002 |